Fresenius SE & Co. KGaA (VIE:FRE)

Austria flag Austria · Delayed Price · Currency is EUR
48.00
+0.79 (1.67%)
At close: Dec 4, 2025
41.26%
Market Cap 26.78B
Revenue (ttm) 22.45B
Net Income (ttm) 1.14B
Shares Out n/a
EPS (ttm) 2.03
PE Ratio 23.43
Forward PE 12.97
Dividend 1.00 (2.08%)
Ex-Dividend Date May 26, 2025
Volume n/a
Average Volume 239
Open 47.55
Previous Close 47.21
Day's Range 47.55 - 48.28
52-Week Range 32.82 - 50.58
Beta n/a
RSI 53.82
Earnings Date Mar 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1912
Employees 176,486
Stock Exchange Vienna Stock Exchange
Ticker Symbol FRE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.